Breast cancer treatment can be safely reduced in women over the age of 70
Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer.
A study published today in
JAMA Network Open by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine sheds new light on this choice and suggests the rate of cancer recurrence or survival may be no different in treated vs. untreated elderly patients diagnosed in the early stages of the cancer diagnosed most commonly in women. As a breast surgeon, I want to give my patients the best chance of survival with the best quality of life, said senior author Priscilla McAuliffe, M.D., Ph.D., surgical oncologist at UPMC Hillman Cancer Center and attending surgeon in the Department of Surgery at Pitt. However, we have found that overtreatment of early-stage breast cancer in older patients may actually cause harm while not improving recurr
Date Time
Breast Cancer Treatment in Those Over 70 Can Be Reduced
Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer. A study published today in JAMA Network Open by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine sheds new light on this choice and suggests the rate of cancer recurrence or survival may be no different in treated vs. untreated elderly patients diagnosed in the early stages of the cancer diagnosed most commonly in women.
“As a breast surgeon, I want to give my patients the best chance of survival with the best quality of life,” said senior author Priscilla McAuliffe, M.D., Ph.D., surgical oncologist at UPMC Hillman Cancer Center and attending surgeon in the Department of Surgery at Pitt. “However, we have found that overtreatment of early-stage breast cancer in older patients may actually cause harm while not improving recurrence
E-Mail
IMAGE: Surgical oncologist at UPMC Hillman Cancer Center and attending surgeon in the Department of Surgery, University of Pittsburgh. view more
Credit: UPMC
PITTSBURGH, April 15, 2021 - Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer. A study published today in
JAMA Network Open by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine sheds new light on this choice and suggests the rate of cancer recurrence or survival may be no different in treated vs. untreated elderly patients diagnosed in the early stages of the cancer diagnosed most commonly in women.
People with cancer that affects the blood, bone marrow or lymph nodes are at elevated risk of COVID-19 vaccine failure, particularly those with chronic lymphocytic leukemia, according to new results
Share this article
Share this article
BETHESDA, Md., April 12, 2021 /PRNewswire/ The American College of Medical Genetics and Genomics (ACMG) welcomed five new directors, including a new president-elect, to its Board of Directors at the 2021 ACMG Annual Clinical Genetics Meeting – A Virtual Experience. The new Board members will serve as advocates for the organization and will assist in shaping and implementing the mission, vision, and direction of the College. The five newly elected directors will serve six-year terms from April 2021 to March 2027. I have enjoyed the chance to meet our recently elected Board members. Each of them offers unique perspectives, new insights and opportunities to advance ACMG s strategic plan, said Anthony Gregg, MD, MBA, FACMG, president of the ACMG. I hope every ACMG member feels comfortable reaching out to the Board with the goal of moving our strategic plan forward. There are many ways to plug in.